Amundi Global Bioenergy UCITS ETF USD Acc

What this fund is

Amundi Global Bioenergy UCITS ETF USD Acc is an exchange-traded fund (ETF) from Amundi, traded under the ticker CWEU (ISIN LU1681046188). It lets you buy a basket of holdings in a single trade, spreading your money across them rather than one company. In plain terms it is about owning small slices of companies, so you share in their growth when they do well — and their falls when they don't, spread broadly across markets worldwide. Rather than a manager picking stocks, it simply replicates the Bloomberg BioEnergy Screened Index index — the passive, low-cost approach, and its largest holdings include NOVONESIS (NOVOZYMES) B, VALERO ENERGY CORPORATION and VEOLIA ENVIRONNEMENT. With about 26 holdings (the ten largest ≈ 75.2%), your money is diversified rather than concentrated in a handful of names.

By geography it is weighted towards ~43.4% United States, ~14.9% Finland and ~12.2% France. Its heaviest sectors are ~43.2% Energy and ~18% Materials. Investors often use a broad fund like this as a long-term 'core' holding — a single building block that covers much of a global portfolio in one trade. Its ongoing charge (TER) is 0.35% a year — about €35 a year on a €10,000 holding, taken automatically from the fund. Income such as dividends is automatically reinvested inside the fund (an accumulating share class), so returns compound without you doing anything.

It holds the underlying investments directly (physical replication); it is domiciled in Luxembourg and UCITS-regulated, a European standard built to protect everyday investors and trades in USD. Its price has swung about 16% over the past year — a gauge of how much the value moves, not a judgement of quality. It launched in 2018. As with any investment, its value can go down as well as up, and past performance is not a guide to future results. (Fund data sourced from Amundi.)